Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R John Looney

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Drugs|March 20, 2010
B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial dataR John Looney
Drugs|April 20, 2006
B cell-targeted therapy for rheumatoid arthritis: an update on the evidenceR John Looney
Arthritis and Rheumatism|May 1, 2007
Will targeting B cells be the answer for Sjögren's syndrome?R John Looney
Open Access Rheumatology : Research and Reviews|June 26, 2009
Update on the use of rituximab for intractable rheumatoid arthritisR John Looney
Current Opinion in Pulmonary Medicine|February 24, 2026
Update on allergen immunotherapy for asthmaR John Looney
The Journal of Rheumatology|November 3, 2005
Discovering that B cells are important in rheumatoid arthritisR John Looney
The Journal of Rheumatology. Supplement|February 5, 2005
B cell-targeted therapy in diseases other than rheumatoid arthritisR John Looney
Clinical Immunology (Orlando, Fla.)|May 16, 2006
B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?William Stohl, R John Looney
Clinical Immunology (Orlando, Fla.)|September 20, 2005
The therapeutic potential of anti-CD20 "what do B-cells do?"Robert Eisenberg, R John Looney
American Journal of Orthopedics (Belle Mead, N.J.)|September 25, 2007
New and promising treatments for rheumatoid arthritisR John Looney, William Stohl
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Drugs|March 20, 2010
B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial dataR John Looney
Drugs|April 20, 2006
B cell-targeted therapy for rheumatoid arthritis: an update on the evidenceR John Looney
Arthritis and Rheumatism|May 1, 2007
Will targeting B cells be the answer for Sjögren's syndrome?R John Looney
Open Access Rheumatology : Research and Reviews|June 26, 2009
Update on the use of rituximab for intractable rheumatoid arthritisR John Looney
Current Opinion in Pulmonary Medicine|February 24, 2026
Update on allergen immunotherapy for asthmaR John Looney
The Journal of Rheumatology|November 3, 2005
Discovering that B cells are important in rheumatoid arthritisR John Looney
The Journal of Rheumatology. Supplement|February 5, 2005
B cell-targeted therapy in diseases other than rheumatoid arthritisR John Looney
Clinical Immunology (Orlando, Fla.)|May 16, 2006
B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?William Stohl, R John Looney
Clinical Immunology (Orlando, Fla.)|September 20, 2005
The therapeutic potential of anti-CD20 "what do B-cells do?"Robert Eisenberg, R John Looney
American Journal of Orthopedics (Belle Mead, N.J.)|September 25, 2007
New and promising treatments for rheumatoid arthritisR John Looney, William Stohl
Pageof 7